traffic information | weather | web feeds| mobile
Silicon Valley
Part of the Bay Area News Group
  • Site
  • Web Search by YAHOO!
Home
News
Venture Capital
Personal Tech
The Valley
Hot Topics
Phones/Mobile
Social Networks
Green Energy
Security
Companies
Apple
Google
Facebook
Cisco Systems
Intel
Hewlett-Packard
Oracle
Yahoo
eBay
Gilead Sciences
Adobe Systems
Intuit
Netflix
Electronic Arts
Tesla Motors
Twitter
Zynga
SunPower
Solyndra
Kleiner Perkins
People
Steve Jobs
Larry Ellison
Eric Schmidt
Mark Zuckerberg
Carol Bartz
John Doerr
John Chambers
Paul Otellini
Vinod Khosla
Mark Andreessen
Ron Conway
Biz Stone
Elon Musk
Larry Page
Sergey Brin
Ann Livermore
Marissa Mayer
Sheryl Sandberg
T.J. Rodgers
Mark Hurd
columnists
gmsv
Special Reports
Venture Capital Survey
Salary Survey
Silicon Valley 150
Services
RSS Feeds
Mobile Edition
Widgets
Contact Us
Jobs
Advertising
Archives
Go to MercuryNews.com
Silicon Valley 150
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Gilead Sciences, Inc. (NQ: GILD)
55.81 USD  +0.33 (+0.59%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
 News
All News
Press Releases
Related Stories
Blogs
Podcasts
 Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Gilead Sciences, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
99.3% Return Seen to Date on SmarTrend Gilead Sciences Call (GILD)
May 24, 2013
from Comtex SmarTrend® News Briefs
Gilead Sciences (GILD) Approaches New Upside Target of $57.45
May 22, 2013
from Comtex SmarTrend® News Briefs
EMA Approves MAA for Gilead's (GILD) Sofosbuvir
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8359487 for the full story. Read More
from StreetInsider.com News Articles
Cramer's Watch List Ahead of Big Cancer Conference
May 20, 2013
The American Society of Clinical Oncology meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer. Read More
category BioMarin Pharmaceutical Inc , Biotechnology , Merck & Co Inc , and 13 more.
from CNBC.com News
Bayer says lung drug shows promise in prolonged trial
May 20, 2013
FRANKFURT, May 20 (Reuters) - Bayer said extended use of its experimental riociguat pill to treat a life-threatening form of high blood pressure in the lungs was shown to be safe and effective in a... Read More
category companyNews
from Reuters: Company News
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8350777 for the full story. Read More
from StreetInsider.com News Articles
Analyst Moves: NOC, GM, GILD
May 17, 2013
This morning, Credit Suisse increased its price target on shares of Northrop Grumman (NOC) to $78 as additional buybacks will boost the stock. In the report, Credit Suisse also increased its EPS... Read More
category Stocks
from Market News Video
AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349940 for the full story. Read More
from StreetInsider.com News Articles
Lightning Round: Starbucks, Gilead & More
May 16, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Read More
category Lightning Round , Starbucks Corp , Dominion Resources Inc , and 10 more.
from CNBC.com News
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of... Read More
category NYSE:JNJ , NYSE:MRK , NASDAQ:PCYC , and 2 more.
from Forbes Real Time
Gilead Offers Response Data from Phase 2 Study of Idelalisib
May 15, 2013
Gilead Sciences, Inc. (Nasdaq: GILD ) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta,... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Experimental Gilead drug effective in early-stage leukemia trial
May 15, 2013
May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into... Read More
category companyNews
from Reuters: Company News
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8340860 for the full story. Read More
from StreetInsider.com News Articles
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
Jim Cramer often advocates themes in the market. These are big picture ideas that he believes will lift the fortunes of companies and by proxy their stocks. Following are 5 themes that he likes right... Read More
category Regeneron Pharmaceuticals Inc , EOG Resources Inc , ENSCO International Incorporated , and 14 more.
from CNBC.com News
Midday Movers: GILD, BSX, AES & More
May 13, 2013
Take a look at some of Monday's midday movers: Read More
category AES Corp , Yum! Brands Inc , Advanced Micro Devices Inc , and 10 more.
from CNBC.com News
Noteworthy ETF Outflows: IYH, GILD, ESRX, MDT
May 13, 2013
Symbols mentioned in this story: IYH, GILD, ESRX, MDT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Highlights on Options Trading for Gilead Sciences
May 13, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ... Read More
from AVAFIN
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Gilead Sciences Shares Up 89.8% Since SmarTrend's Buy Recommendation (GILD)
May 10, 2013
from Comtex SmarTrend® News Briefs
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure
May 08, 2013
Following successful in vitro studies, Danish researchers are on the fast track to human clinical trials. Read More
category MRK , GILD , BMY
from Minyanville Headlines
Many in U.S. don't get proper testing for hepatitis C- CDC
May 07, 2013
NEW YORK, May 7 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials said on... Read More
category companyNews
from Reuters: Company News
Gilead Sciences (GILD) Approaches New Downside Target of $53.17
May 07, 2013
from Comtex SmarTrend® News Briefs
Daily Options Trading for Gilead Sciences
May 07, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading options contracts during the market ... Read More
from AVAFIN
Gilead Sciences (GILD) Shows High Options Volume
May 06, 2013
 Read More
category NYSE:BAC , NYSE:AIG , NASDAQ:FB , and 2 more.
from InvestorPlace - Latest Headlines
PhD Biopharma CEOs: Better, Bolder, Or Occasionally Lucky?
May 04, 2013
For as long as I can remember, it’s been fashionable for management consultants to attribute many of the challenges of biopharmaceutical companies to scientists run amuck (a perspective both summarized... Read More
category NASDAQ:GILD , NYSE:LLY
from Forbes Real Time
Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data
May 03, 2013
The U.S. stock market jumped on Friday to end the trading week. The catalyst for the move higher was a strong jobs report, which briefly sent the Dow Jones Industrial Average over 15,000 for the first... Read More
category LNKD , Earnings , Benzinga , and 29 more.
from Latest Articles from Benzinga.com
US STOCKS-Dow, S&P 500 close at record levels after jobs report
May 03, 2013
* Payrolls report shows more jobs added in April than expected Read More
category companyNews
from Reuters: Company News
Notable 52-Week Highs and Lows of the Day 05/03: (AIG) (STX) (GILD) High; (DCTH) (ZAGG) (VCRA) Low
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8304235 for the full story. Read More
from StreetInsider.com News Articles
US STOCKS-Dow, S&P 500 surge to records after U.S. payrolls report
May 03, 2013
* Payroll report shows more jobs added in April than expected Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
  • Terms of Use & Privacy Statement
  • Copyright ©
  • About our Ads
  • Find San Jose jobs
  • About MediaNews Group
  • RSS
  • About Bay Area News Group
  • Site Map

Media News Group